Antios Therapeutics Inc. — Form D

Antios Therapeutics Inc. of MENDHAM, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-17. The offering totals $5.0M, of which $4.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Henry Lin ChenDirectorGRAND CAYMAN, E9
Nicole VitulloDirectorAtlanta, GA
Abel De La RosaExecutive OfficerPhiladelphia, PA
Idean MarvastyExecutive OfficerAtlanta, GA
Douglas Lin MayersExecutive OfficerAtlanta, GA
Gregory MayesDirectorMorristown, NJ
Gregory MayesExecutive OfficerMorristown, NJ
CRAIG GORDONDirectorNOVATO, CA
DAVID CANNERDirectorSEATTLE, WA
Benjamin RovinskiDirectorMendham, NJ
Scott MorensteinDirectorMendham, NJ
Tamra AdamsExecutive OfficerMendham, NJ
Abel De La RosaDirectorPhiladelphia, PA
Douglas MayersExecutive OfficerMendham, NJ
Patrick HigginsDirectorPhiladelphia, PA
Iyona RajkomarDirectorMendham, NJ
Nicole VitulioDirectorAtlanta, GA

Other filings by this issuer (3)

FiledFormOfferingSold
2021-11-16D$86.0M$75.0M
2021-04-19D$100.0M$32.0M
2018-12-05D$25.0M$15.0M

More